<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00040131</url>
  </required_header>
  <id_info>
    <org_study_id>P02580</org_study_id>
    <nct_id>NCT00040131</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a single dose of IL-10 compared to placebo is
      safe and effective in reducing the incidence of post-ERCP acute pancreatitis for subjects
      with increased risk.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">January 2003</completion_date>
  <primary_completion_date type="Actual">December 2002</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Actual">316</enrollment>
  <condition>Bile Duct Diseases</condition>
  <condition>Biliary Tract Diseases</condition>
  <condition>Gallbladder Diseases</condition>
  <condition>Pancreatitis</condition>
  <condition>Pancreatic Diseases</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IL-10</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        Adults weighing up to 125 kg who are undergoing ERCP for any of the following:

          -  Evaluate recurrent abdominal pain;

          -  Evaluate unexplained recurrent pancreatitis;

          -  Evaluate prior post-ERCP pancreatitis;

          -  Treatment of pancreatic disorders;

          -  Treatment of Common Bile Duct Stones (without jaundice)

        Exclusion criteria:

          -  Active (acute) pancreatitis;

          -  Chronic pancreatitis (moderate and severe cases);

          -  ERCP to perform a second procedure on biliary tract;

          -  Patients who previously had pancreatic sphincterotomy;

          -  Known or suspected pancreatic cancer or cancer of Papilla of Vater;

          -  Known or suspected other malignancy;

          -  History of, or current clotting or bleeding problems;

          -  Moderate and severe Anemia;

          -  Low platelet counts
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Chile</country>
    <country>France</country>
    <country>Italy</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2002</study_first_submitted>
  <study_first_submitted_qc>June 20, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2002</study_first_posted>
  <last_update_submitted>October 30, 2015</last_update_submitted>
  <last_update_submitted_qc>October 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatic Diseases</mesh_term>
    <mesh_term>Gallbladder Diseases</mesh_term>
    <mesh_term>Biliary Tract Diseases</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

